News
May 7, 2025
MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device
Lund, Sweden – May 6, 2025 – MedVasc AB, a Swedish medical technology company announces the successful closing of a SEK 10 million financing round earlier this year. The funding supports the company’s final product development phase and preparation for regulatory approval in the United States. The primary focus of the…
May 7, 2025
Dr. Michael Åkesson featured on stage at the American Venous Forum, Atlanta
Our founder Dr. Michael Åkesson was invited to present the results from our first-in-man clinical study at the American Venous Forum in Athens in February. We are very happy to see that there is such great interest from the Venous community and we look forward to bringing SolutioTM in to the hands of…
July 1, 2024
SolutioTM featured on stage at the European Venous Forum in Athens
Our founder Dr. Michael Åkesson was invited to present the results from our first-in-man clinical study at the European Venous Forum in Athens last week. We are very happy to see that there is such great interest from the Venous community – we look forward to bringing SolutioTM in to the…
May 24, 2024
Vinnova awards MedVasc a grant for a better understanding of reimbursement in the US
MedVasc has been awarded a grant of SEK 135,000 from Vinnova (Swedish Innovation Agency) to enhance the company’s understanding of the reimbursement landscape in the US. This support was secured through the Medtech4Health call 2024, aiming at strengthening small medtech companies through external competence. By the end of the…
May 3, 2024
SolutioTM featured on center stage at 2024 International Venous Conference
MedVasc anesthesia catheter SolutioTM gained attention during 2024 International Venous Conference as renowned KOL Dr. Lowell Kabnick gave a talk about next-generation venous devices: …
For press inquiries, please send an email
Subscribe to our newsletter
For more information on how we process your personal data please see our Privacy Notice
